Science Explorer Back to mapMap
Discussion
Company · Wurzburg · Germany

Vasopharm (Germany)

vasopharm.comROR OpenAlex
Research works
10
▼ 100% vs 2018-21
Citations
512
50.1 per fractional work
Top-10% rate
15.3%
all institutions 10.0%
Open access
34%
world 40%
International
32%
world 18%
Vasopharm (Germany)

Not ranked overall: Vasopharm (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vasopharm (Germany) work in?

In all years, 51% of research at Vasopharm (Germany) is in Health Sciences, 47% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (38%), Immunology and Microbiology (6%). It does 1.7× the world's share of Life Sciences.

Health Sciences: 5 fractional works · 51.0% of its workMedicine: 5 fractional works · 51.0% of its workPhysiology: 2 fractional works · 18.6% of its workNephrology: 1 fractional works · 7.4% of its workNeurology: 1 fractional works · 6.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 4.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 3.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.7% of its workOncology: 0 fractional works · 2.7% of its workEpidemiology: 0 fractional works · 1.4% of its workHematology: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 1.1% of its workInternal Medicine: 0 fractional works · 0.8% of its workLife Sciences: 5 fractional works · 46.9% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 37.8% of its workMolecular Biology: 2 fractional works · 21.4% of its workClinical Biochemistry: 1 fractional works · 13.6% of its workBiochemistry: 0 fractional works · 2.1% of its workCell Biology: 0 fractional works · 0.8% of its workImmunology and Microbiology: 1 fractional works · 6.0% of its workImmunology: 1 fractional works · 6.0% of its workAgricultural and Biological Sciences: 0 fractional works · 1.5% of its workPlant Science: 0 fractional works · 1.5% of its workNeuroscience: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 1.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workPhysical Sciences: 0 fractional works · 2.1% of its workEnvironmental Science: 0 fractional works · 1.7% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.7% of its workChemistry: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.4% of its workALL ITS WORKVasopharm(Germany)10fractional works, all years
Life Sciences47%Physical Sciences2%Health Sciences51%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 8 fields, with their numbers
    1. Medicine551.0%
    1. Biochemistry, Genetics and Molecular Biology437.8%
    2. Immunology and Microbiology16.0%
    3. Agricultural and Biological Sciences01.5%
    4. Neuroscience01.1%
    5. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Environmental Science01.7%
    2. Chemistry00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from Vasopharm (Germany)?

    The most cited paper from Vasopharm (Germany) is "The NOX toolbox: validating the role of NADPH oxidases in physiology and disease" (Sebastian Altenhöfer, Pamela W. M. Kleikers, Kim A. Radermacher et al., 2012), with 386 citations. Next come "Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation☆" (255) and "Comparative pharmacology of chemically distinct NADPH oxidase inhibitors" (239).

    Most cited papers
    #PaperReleasedCitations
    1 The NOX toolbox: validating the role of NADPH oxidases in physiology and disease Sebastian Altenhöfer, Pamela W. M. Kleikers, Kim A. Radermacher et al. · Cellular and Molecular Life Sciences Open access 30 May 2012 386
    2 Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation☆ Henrik ten-Freyhaus, Michael Huntgeburth, Kirstin Wingler et al. · Cardiovascular Research Open access 21 Mar 2006 255
    3 Comparative pharmacology of chemically distinct NADPH oxidase inhibitors Sven Wind, Knut Beuerlein, Thomas Eucker et al. · British Journal of Pharmacology Open access 17 Jun 2010 239
    4 Monitoring of Clopidogrel Action: Comparison of Methods Jörg R. P. Geiger, Lino Lars Teichmann, R. Großmann et al. · Clinical Chemistry 8 Apr 2005 179
    5 Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells Claudia Stielow, Rusan Ali Catar, Gregor M. Müller et al. · Biochemical and Biophysical Research Communications 30 Mar 2006 125
    All 24 most cited papers, with filters and sorting

    Which research topics does Vasopharm (Germany) publish most on?

    By volume: Nitric Oxide and Endothelin Effects, Metabolism and Genetic Disorders, Phosphodiesterase function and regulation and Receptor Mechanisms and Signaling.

    Nitric Oxide and Endothe…2Nitric Oxide and Endothelin Effects: 2 fractional worksMetabolism and Genetic D…1Metabolism and Genetic Disorders: 1 fractional worksPhosphodiesterase functi…1Phosphodiesterase function and regulation: 1 fractional worksReceptor Mechanisms and Signaling: 1 fractional worksTraumatic Brain Injury and Neurovascular Disturbances: 1 fractional worksElectrolyte and hormonal…0Electrolyte and hormonal disorders: 0 fractional worksNeutrophil, Myeloperoxidase and Oxidative Mechanisms: 0 fractional worksAcute Kidney Injury Research: 0 fractional worksAdvanced Glycation End Products research: 0 fractional worksRenal function and acid-base balance: 0 fractional works
    PhysiologyClinical BiochemistryMolecular BiologyNeurology3 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Nitric Oxide and Endothelin Effects Physiology 2 works
    2. 2 Metabolism and Genetic Disorders Clinical Biochemistry 1 works
    3. 3 Phosphodiesterase function and regulation Molecular Biology 1 works
    4. 4 Receptor Mechanisms and Signaling Molecular Biology 1 works
    5. 5 Traumatic Brain Injury and Neurovascular Disturbances Neurology 1 works
    6. 6 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 0 works
    7. 7 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
    8. 8 Acute Kidney Injury Research Nephrology 0 works
    9. 9 Advanced Glycation End Products research Clinical Biochemistry 0 works
    10. 10 Renal function and acid-base balance Nephrology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available34.0%not open66.0%

    World: 40% of research is openly available.

    with international co-authors31.5%domestic only68.5%

    World: 18% is written across borders.

    How has Vasopharm (Germany)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    2005201020152020
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Vasopharm (Germany) as a percentage of every work published that year, 0.000021% in 2019.

    0.00010%0.00020%Vasopharm (Germany)0.0000012% in 202020102020

    Fractional works of Vasopharm (Germany) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Wurzburg

    All research institutions in Wurzburg

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Vasopharm (Germany). Posts are plain text and can be reported.